(Q36333225)

13 August 2017

1 reference

title

Zygomycosis: an emerging fungal infection (English)

1 reference

13 August 2017

1 reference

Jack Brown

1

0 references

publication date

1 December 2005

1 reference

American Journal of Health-System Pharmacy

13 August 2017

published in

1 reference

13 August 2017

volume

62

1 reference

13 August 2017

issue

24

1 reference

13 August 2017

page(s)

2593-2596

1 reference

Increase in aspergillosis and severe mycotic infection in patients with leukemia and MDS: comparison of the data from the Annual of the Pathological Autopsy Cases in Japan in 1989, 1993 and 1997.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

The changing spectrum of disease, etiology, and diagnosis of mucormycosis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Pulmonary mucormycosis: results of medical and surgical therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Risk of tongue depressors to the immunocompromised

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Zygomycosis: reemergence of an old pathogen

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Zygomycosis in the 1990s in a tertiary-care cancer center

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Two case reports: fatal Absidia corymbifera pulmonary tract infection in the first postoperative phase of a lung transplant patient receiving voriconazole prophylaxis, and transient bronchial Absidia corymbifera colonization in a lung transplant pat

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Sinus zygomycosis in a patient receiving voriconazole prophylaxis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto).

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Pulmonary mucormycosis: the last 30 years

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Subcutaneous mucormycosis caused by Mucor hiemalis Wehmer f. luteus (Linnemann) Schipper 1973.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

An amphotericin B-resistant case of rhinocerebral mucor mycosis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Complete resolution of pulmonary Rhizopus oryzae infection with itraconazole treatment: more evidence of the utility of azoles for zygomycosis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

In vitro susceptibilities of zygomycetes to conventional and new antifungals

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Combined anti-fungal therapy and surgical resection as treatment of pulmonary zygomycosis in allogeneic bone marrow transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Role of granulocyte colony-stimulating factor in the treatment of mucormycosis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

Soft-tissue fungal infections: surgical management of 12 immunocompromised patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050188

31 March 2020

Identifiers

DOI

10.2146/AJHP050188

1 reference

13 August 2017

1 reference